THE TARGET-CELL NUCLEUS IS NOT REQUIRED FOR CELL-MEDIATED GRANZYME-BASED OR FAS-BASED CYTOTOXICITY

被引:89
作者
NAKAJIMA, H
GOLSTEIN, P
HENKART, PA
机构
[1] NCI,EXPTL IMMUNOL BRANCH,BETHESDA,MD 20892
[2] CNRS,INSERM,CTR IMMUNOL,F-13288 MARSEILLE 9,FRANCE
关键词
D O I
10.1084/jem.181.5.1905
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The requirement for target cell nuclei in the two apoptotic death pathways used by cytotoxic lymphocytes was tested using model effector systems in which the granzyme and Fas pathways of target damage are isolated. Mast cell tumors expressing granzymes A and B in addition to cytolysin/perforin lysed tumor target cells about 10-fold more efficiently than comparable effector cells without granzymes. Enucleated cytoplast targets derived from these cells were also lysed with a similar 10-fold effect of granzymes. In contrast to cytoplasts, effector granzyme expression did not influence lysis of red cell targets. The Fas pathway was assessed using the selected cytotoxic T lymphocyte hybridoma subline d11S, which lysed target cells expressing Fas but not those lacking Fas. Similarly, cytoplasts derived from Fas(+) but not Fas(-) cells were also readily lysed by these effector cells. Thus, neither the nucleus itself nor the characteristic apoptotic nuclear damage associated with the two major cell death pathways used by cytotoxic lymphocytes are required for cell death per se.
引用
收藏
页码:1905 / 1909
页数:5
相关论文
共 30 条
[1]  
Kagi D., Vignaux F., Ledermann B., Burki K., Depraetere V., Nagata S., Hengartner H., Golstein P., Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity, Science (Wash. DC), 265, pp. 528-530, (1994)
[2]  
Kojima H., Shinohara N., Hanaoka S., Someya-Shirota Y., Takagaki Y., Ohno H., Saito T., Katayama T., Yagita H., Okumura K., Et al., Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes, Immunity., 1, pp. 357-364, (1994)
[3]  
Lowin B., Hahne M., Mattmann C., Tschopp J., Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways, Nature (Lond.), 370, pp. 650-652, (1994)
[4]  
Henkart P.A., Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules, Immunity., 1, pp. 343-346, (1994)
[5]  
Russell J.H., Internal disintegration model of cytotoxic lymphocyte-induced target damage, Immunol. Rev., 72, pp. 97-118, (1983)
[6]  
Shi L., Nishioka W.K., Thng J., Bradbury E.M., Litchfield D.W., Greenberg A.H., Premature p34cdc2 activation required for apoptosis, Science (Wash. DC), 263, pp. 1143-1145, (1994)
[7]  
Yonehara S., Ishii A., Yonehara M., A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor, J. Exp Med., 169, pp. 1747-1756, (1989)
[8]  
Nakajima H., Park H., Henkart P.A., Synergistic roles of granzymes A and B in mediating target cell death by RBL mast cell tumors also expressing cytolysin/perforin, J. Exp Med., 181, pp. 1037-1046, (1995)
[9]  
Bissonnette R.P., Echeverri F., Mahboubi A., Green D.R., Apoptotic cell death induced by c-myc is inhibited by bcl-2, Nature (Lond.), 359, pp. 552-554, (1992)
[10]  
Collins M.K.L., Rivas A.L., The control of apoptosis in mammalian cells, Trends Biochem. Sci., 18, pp. 307-309, (1993)